» Articles » PMID: 20051274

Functional and Association Analysis of Frizzled 1 (FZD1) Promoter Haplotypes with Femoral Neck Geometry

Overview
Journal Bone
Date 2010 Jan 7
PMID 20051274
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Frizzleds are receptors for Wnt signaling and are involved in skeletal morphogenesis. Little is known about the transcriptional regulation of frizzleds in bone cells. In the current study, we determined if two common and potentially functional genetic variants (rs2232157, rs2232158) in the frizzled-1 (FZD1) promoter region and their haplotypes influence FZD1 promoter activity in human osteoblast-like cells. We also determined if these variants are associated with femoral neck bone mineral density (BMD) and geometry in 1319 African ancestry men aged > or =40 years. Real-time quantitative PCR and western blot analysis demonstrated FZD1 mRNA and protein expression in the human osteoblast-like cell lines, MG63 and SaOS-2. Promoter activity was next assessed by transient expression of haplotype specific FZD1 promoter reporter plasmids in these cells. In comparison to the common GG haplotype, promoter activity was 3-fold higher for the TC haplotype in both cell lines (p<0.05). We previously demonstrated that rs2232158 is associated with differential FZD1 promoter activity and Egr1 binding and thus focused further functional analyses on the rs2232157 G-to-T polymorphism. Electrophoretic mobility shift assay demonstrated that distinct nuclear protein complexes were associated with rs2232157 in an allele specific manner. Bioinformatics analysis predicted that the G to T transversion creates an E2F1 binding site, further supporting the functional significance of rs2232157 in FZD1 promoter regulation. Individual SNPs and haplotypes were not associated with femoral neck BMD. The TC haplotype was associated with larger subperiosteal width and greater CSMI (p<0.05). These results suggest that FZD1 expression is regulated in a haplotype-dependent manner in osteoblasts and that these same haplotypes may be associated with biomechanical indices of bone strength.

Citing Articles

The landscape of GWAS validation; systematic review identifying 309 validated non-coding variants across 130 human diseases.

Alsheikh A, Wollenhaupt S, King E, Reeb J, Ghosh S, Stolzenburg L BMC Med Genomics. 2022; 15(1):74.

PMID: 35365203 PMC: 8973751. DOI: 10.1186/s12920-022-01216-w.


The role of GPCRs in bone diseases and dysfunctions.

Luo J, Sun P, Siwko S, Liu M, Xiao J Bone Res. 2019; 7:19.

PMID: 31646011 PMC: 6804689. DOI: 10.1038/s41413-019-0059-6.


Transcriptional Regulation of Frizzled-1 in Human Osteoblasts by Sp1.

Yu S, Yerges-Armstrong L, Chu Y, Zmuda J, Zhang Y PLoS One. 2016; 11(10):e0163277.

PMID: 27695039 PMC: 5047477. DOI: 10.1371/journal.pone.0163277.


E2F1 effects on osteoblast differentiation and mineralization are mediated through up-regulation of frizzled-1.

Yu S, Yerges-Armstrong L, Chu Y, Zmuda J, Zhang Y Bone. 2013; 56(2):234-41.

PMID: 23806799 PMC: 3758927. DOI: 10.1016/j.bone.2013.06.019.


The genetic pleiotropy of musculoskeletal aging.

Karasik D, Cohen-Zinder M Front Physiol. 2012; 3:303.

PMID: 22934054 PMC: 3429074. DOI: 10.3389/fphys.2012.00303.

References
1.
Duan Y, Seeman E, Turner C . The biomechanical basis of vertebral body fragility in men and women. J Bone Miner Res. 2002; 16(12):2276-83. DOI: 10.1359/jbmr.2001.16.12.2276. View

2.
Wu L, Timmers C, Maiti B, Saavedra H, Sang L, Chong G . The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 2001; 414(6862):457-62. DOI: 10.1038/35106593. View

3.
Tabensky A, Duan Y, Edmonds J, Seeman E . The contribution of reduced peak accrual of bone and age-related bone loss to osteoporosis at the spine and hip: insights from the daughters of women with vertebral or hip fractures. J Bone Miner Res. 2001; 16(6):1101-7. DOI: 10.1359/jbmr.2001.16.6.1101. View

4.
Streeten E, Beck T, OConnell J, Rampersand E, McBride D, Takala S . Autosome-wide linkage analysis of hip structural phenotypes in the Old Order Amish. Bone. 2008; 43(3):607-12. PMC: 2591020. DOI: 10.1016/j.bone.2008.04.005. View

5.
Bunker C, Patrick A, Konety B, Dhir R, Brufsky A, Vivas C . High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev. 2002; 11(8):726-9. View